ERIS Lifescience

ERIS28 Mar 2024
Pharmaceuticals
+1.50 (+0.18%)
Lowest Today
Highest Today
Today’s Open
Prev. Close
52 Week High
52 Week Low
To Invest in ERIS Lifescience
ERIS Lifescience
Pharmaceuticals
ERIS28 Mar 2024
+1.50 (+0.18%)
OverviewFundamentals
1D
1M
6M
1Y
5Y
All

ERIS Lifescience - Share Price & Details

Lowest Today
831
Highest Today
861.85
Today’s Open
840
Prev. Close
841.05
52 Week High
971
52 Week Low
557
Traded Volume
Market Cap(Cr)
Avg Traded Price
1 Year return
47.58%
Upper Circuit
Lower Circuit
P/E TTM
32.87
P/B Ratio
4.67
Traded Value(Cr)
0.05
EPS TTM
25.59
Book value
Dividend
0.87%

Price Performance

0.31 %
1 Wk
-3.53 %
1 M
-7.71 %
3 M
47.58 %
1 Y
-7.08 %
YTD

Traded Volume Movement

Technical Details

Support 3
800
Support 2
816
Support 1
831
Pivot Point :
847
Resistance 1
861
Resistance 2
877
Resistance 3
891

Reports

Peer Comparison

Scrip NamePriceDaily ChangeM.Cap (Cr)1 Year Returns %P/E (TTM)PB Ratio
ERIS Lifesciences Ltd
₹842.55(+1.50/0.18%)
842.55+1.5011,440.6647.5832.874.67
Cipla Ltd
₹1,491.70(+25.50/1.74%)
1,491.70+25.50118,375.9264.8436.004.57
Bliss GVS Pharma Ltd
₹113.80(-0.35/-0.31%)
113.80-0.351,195.0559.7417.511.22
Astrazeneca Pharma India Ltd
₹5,365.00(+45.25/0.85%)
5,365.00+45.2513,299.3859.3683.3820.31
Abbott India Ltd
₹27,133.65(+385.20/1.44%)
27,133.65+385.2056,840.4624.8349.6218.28
Amrutanjan Health Care Ltd
₹618.75(+7.55/1.24%)
618.75+7.551,767.020.8240.166.74

About ERIS Lifesciences Ltd

ERIS Lifesciences Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 11440.66 crores. It has reported a sales of Rs. 315.96 crores and a net profit of Rs. 31.66 crores for the quarter ended December 2018. The company management includes Amit Indubhushan Bakshi, Amit Indubhushan Bakshi,Kaushal Kamlesh Shah,Inderjeet Singh Negi,Krishnakumar Vaidyanathan,Sujesh Vasudevan,Prashant Gupta,Rajeev Narotam Dalal,Kalpana Unadkat (ERIS Lifesciences Ltd) among others.
Chairman
Amit Indubhushan Bakshi
Registered office
8th Floor Commerce House -IV,Prahladnagar 100 FT Road,Ahmedabad,Gujarat,380015
FAX :91-79-48903474
Background
Incorporation Year2007
Face Value₹1
Market Lot1

Latest News

Mid-day Mood | Sensex, Nifty trade 1% up as bank, tech stocks gain
The Sensex and Nifty 50 extended early gains and rose over 1 percent each around noon on March 28, led by gains in financial services and IT sectors. Analysts expect some sort of volatility ahead of the monthly derivatives expiry today. With an impending long weekend, exercising caution by refraining from aggressive overnight positions would be prudent to mitigate undue risks.
28 Mar 2024 | 12:49 PM
Banking stocks drive Sensex 350 pts higher, Nifty above 22,200
Tracking positive cues from global peers and ahead of a key U.S. inflation reading, Indian shares opened higher on the final trading day of the financial year 2024, led by banking and financial stocks.The Sensex was trading 256 points or 0.36% higher at 73,265. Nifty50 was trading at 22,197, up 73 points or 0.33% at around 9.21 am.From the Sensex stock, Bajaj Finance, Bajaj Finserv, ICICI Bank.
28 Mar 2024 | 11:10 AM
📢 Benchmark indices open on a positive note today; Nifty above 22,200
📊 Amid positive global cues, benchmark indices started on a positive note today.
📢  At 9:16 AM, the Sensex gained 210.24 points or 0.29% at 73,206.55. Nifty is higher by 67.70 points or 0.31% at 22,191.35
📈 BHEL (⬆️3.39%), Biocon (⬆️1.33%) and Ambuja Cements (⬆️0.99%) appeared as the top performers on the Nifty50 at the open. Bajaj Finance and JSW Energy. stocks are in focus today.
28 Mar 2024 | 09:22 AM
Will Nifty end March series above 22,200 mark or see a further downfall?
GIFT Nifty indicated that Indian equity indices BSE Sensex and NSE Nifty 50 may see a positive opening on Thursday. Here is all you need to know before the market opens. GIFT Nifty traded up by 33 points or 0.15% at 22,214 indicating a positive opening for domestic indices NSE Nifty 50 and BSE Sensex on Thursday. Previously, on Wednesday, the NSE Nifty 50 ended up by 118.95 points or 0.54% .
28 Mar 2024 | 09:13 AM
Mid-day Mood | Sensex, Nifty trade 1% up as bank, tech stocks gain
The Sensex and Nifty 50 extended early gains and rose over 1 percent each around noon on March 28, led by gains in financial services and IT sectors. Analysts expect some sort of volatility ahead of the monthly derivatives expiry today. With an impending long weekend, exercising caution by refraining from aggressive overnight positions would be prudent to mitigate undue risks.
28 Mar 2024 | 12:49 PM

How to buy ERIS Lifescience shares on nse?

To buy ERIS Lifescience shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the ERIS Lifescience share price today?

The ERIS Lifescience shares price on nse is Rs.842.55 today.

What is the market cap of ERIS Lifescience shares on BSE ?

The company has a market capitalization of Rs.11440.66Cr

What is the PE & PB ratio of ERIS Lifescience shares ?

PE is 32.87 and PB is 4.67

What is the 52 Week High and Low of ERIS Lifescience shares?

ERIS Lifescience stock price high: Rs.971 ERIS Lifescience stock price low: Rs.557

What is the price of ERIS Life Sciences stocks on BSE?

The price of ERIS Life Sciences as of the end of day 17th April 2023 was INR 612.6 on BSE.

Is it safe to buy ERIS Life Sciences?

ERIS Life Sciences net profit has increased from Rs. 291.15 crores to Rs. 405.79 crores in the last four years. And the company's sales revenue has grown from Rs.982.6 crores to Rs. 1347 crores in the last four years. 

ERIS Life Sciences stock 52 weeks low is Rs.551.3 and high is Rs.749.8.

Equity investment is a risk like any other investment and it is advisable to take professional advice before investing.  

 

What is the current market value per stock of ERIS Life Sciences?

The current market value (or market capitalization) of ERIS Life Sciences is approximately Rs. 8.33K crores as on 17th April 2023.

Does ERIS Life Science have any debts?

ERIS Life Sciences has a debt-to-equity ratio of 0.13.  

 

Will ERIS Life Science stock price increase?

Eris Life Sciences is a pharmaceutical company based in India that focuses on developing, manufacturing, and marketing branded pharmaceutical products across various therapeutic areas. The company's products are sold in India and other countries, including Nepal, Sri Lanka, and Mauritius.

However, it is near impossible to predict the future movements of stock prices, as they are linked to a wide range of variables, including market trends, economic conditions, company performance, and global events.

It's imperative to conduct thorough research and due diligence in making any investment decisions. And to consider several relevant factors that could impact the company's future prospects.

 

Should I buy or sell ERIS Life Science?

ERIS Life Sciences stock has given a positive return of 33.61%  over the last 3 years and a negative return of -12.85% over the past 12 months.  

Selling or buying of specific stock or stocks depends on your personal financial goals and risk tolerance. 

 

setTimeout(function() { }, 5000);